By targeting upstream cytokines such as IL-23, IL-1, IL-6 and IFN-γ, JAK1/TYK2 inhibitors could suppress both the core Th17 response and these plastic Th2 elements, offering a mechanistic rationale for broader immunomodulatory efficacy in PPP [25–27]. This evidence concerns the gene IL1B and palmoplantar pustulosis.